Advanced Molecular Detection (AMD) and Response to Infectious Disease Outbreaks

Related Pages

Advanced molecular detection (AMD) integrates the latest next-generation genomic sequencing technologies with bioinformatics and epidemiology expertise across CDC and the nation to help us find, track, and stop disease-causing pathogens faster than ever before.

What's New
SARS-CoV-2 Innovation: Broad Agency Announcement awards

Posted on Friday, July 2, 2021

The Centers for Disease Control and Prevention (CDC) has issued awards as part of the SARS-CoV-2 Sequencing for Public Health Emergency Response, Epidemiology, and Surveillance (SPHERES) Initiative. The awards are intended to fill knowledge gaps and promote innovation in the U.S. response to the COVID-19 pandemic.

Learn more on our What's New page
lab with large sequencer equipment on the counter
COVID-19 Genomic Epidemiology Toolkit
Learn more
illustration of PulseNet scientists with a background that symbolizes the transition from PFGE technology to whole genome sequencing technology
Resources and Print Materials
Learn More
Two lab scientists preparing vials for sequencing using a large machine
Who We Are
Scientist identifying pathogens on a computer screen.
What We Do
Closeup of a flow cell for an Illumina sequencing machine held by hands in blue gloves. The scientist's face can be seen in the background.
What's New
A scientist working with samples in a lab.
How it Works
Follow us @CDC_AMD
Related Links

Page last reviewed: July 2, 2021
Content source: Centers for Disease Control and Prevention